» Articles » PMID: 27283753

Brain and Behaviour Phenotyping of a Mouse Model of Neurofibromatosis Type-1: an MRI/DTI Study on Social Cognition

Overview
Date 2016 Jun 11
PMID 27283753
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Neurofibromatosis type-1 (NF1) is a common neurogenetic disorder and an important cause of intellectual disability. Brain-behaviour associations can be examined in vivo using morphometric magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) to study brain structure. Here, we studied structural and behavioural phenotypes in heterozygous Nf1 mice (Nf1(+/-) ) using T2-weighted imaging MRI and DTI, with a focus on social recognition deficits. We found that Nf1(+/-) mice have larger volumes than wild-type (WT) mice in regions of interest involved in social cognition, the prefrontal cortex (PFC) and the caudate-putamen (CPu). Higher diffusivity was found across a distributed network of cortical and subcortical brain regions, within and beyond these regions. Significant differences were observed for the social recognition test. Most importantly, significant structure-function correlations were identified concerning social recognition performance and PFC volumes in Nf1(+/-) mice. Analyses of spatial learning corroborated the previously known deficits in the mutant mice, as corroborated by platform crossings, training quadrant time and average proximity measures. Moreover, linear discriminant analysis of spatial performance identified 2 separate sub-groups in Nf1(+/-) mice. A significant correlation between quadrant time and CPu volumes was found specifically for the sub-group of Nf1(+/-) mice with lower spatial learning performance, suggesting additional evidence for reorganization of this region. We found strong evidence that social and spatial cognition deficits can be associated with PFC/CPu structural changes and reorganization in NF1.

Citing Articles

Social Communication in Ras Pathway Disorders: A Comprehensive Review From Genetics to Behavior in Neurofibromatosis Type 1 and Noonan Syndrome.

Siqueiros-Sanchez M, Serur Y, McGhee C, Smith T, Green T Biol Psychiatry. 2024; 97(5):461-498.

PMID: 39366539 PMC: 11805629. DOI: 10.1016/j.biopsych.2024.09.019.


A new era for myelin research in Neurofibromatosis type 1.

de Blank P, Nishiyama A, Lopez-Juarez A Glia. 2023; 71(12):2701-2719.

PMID: 37382486 PMC: 10592420. DOI: 10.1002/glia.24432.


Neurobehavioral sex-related differences in Nf1 mice: female show a "camouflaging"-type behavior.

Santos S, Martins B, Sereno J, Martins J, Castelo-Branco M, Goncalves J Biol Sex Differ. 2023; 14(1):24.

PMID: 37101298 PMC: 10131355. DOI: 10.1186/s13293-023-00509-8.


Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of Rapamycin.

Sato A, Ikeda K Biol Psychiatry Glob Open Sci. 2022; 2(2):95-105.

PMID: 36325164 PMC: 9616270. DOI: 10.1016/j.bpsgos.2021.08.005.


Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.

Miller A, Halloran M Dis Model Mech. 2022; 15(8).

PMID: 36037004 PMC: 9459395. DOI: 10.1242/dmm.049422.


References
1.
Shilyansky C, Karlsgodt K, Cummings D, Sidiropoulou K, Hardt M, James A . Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A. 2010; 107(29):13141-6. PMC: 2919968. DOI: 10.1073/pnas.1004829107. View

2.
Walsh K, Velez J, Kardel P, Imas D, Muenke M, Packer R . Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol. 2012; 55(2):131-138. DOI: 10.1111/dmcn.12038. View

3.
Zoller M, Rembeck B, Backman L . Neuropsychological deficits in adults with neurofibromatosis type 1. Acta Neurol Scand. 1997; 95(4):225-32. DOI: 10.1111/j.1600-0404.1997.tb00103.x. View

4.
Gutmann D, Wu Y, Hedrick N, Zhu Y, Guha A, Parada L . Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet. 2001; 10(26):3009-16. DOI: 10.1093/hmg/10.26.3009. View

5.
Zamboni S, Loenneker T, Boltshauser E, Martin E, Ilyasov K . Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. AJNR Am J Neuroradiol. 2007; 28(4):773-6. PMC: 7977343. View